Providing perspective for interpreting cardiovascular mortality risks associated with ozone exposures  by Petito Boyce, Catherine et al.
Regulatory Toxicology and Pharmacology 72 (2015) 107–116Contents lists available at ScienceDirect
Regulatory Toxicology and Pharmacology
journal homepage: www.elsevier .com/locate /yr tphProviding perspective for interpreting cardiovascular mortality risks
associated with ozone exposureshttp://dx.doi.org/10.1016/j.yrtph.2015.03.009
0273-2300/ 2015 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑ Corresponding author. Fax: +1 617 395 5001.
E-mail addresses: cpetitoboyce@gradientcorp.com (C. Petito Boyce), jgoodman@
gradientcorp.com (J.E. Goodman), ssax@gradientcorp.com (S.N. Sax), cloftus@
gradientcorp.com (C.T. Loftus).Catherine Petito Boyce a, Julie E. Goodman b,⇑, Sonja N. Sax b, Christine T. Loftus a
aGradient, 600 Stewart Street, Ste 1900, Seattle, WA 98101, USA
bGradient, 20 University Road, Ste 5, Cambridge, MA 02138, USA
a r t i c l e i n f o a b s t r a c tArticle history:
Received 20 February 2015
Available online 24 March 2015
Keywords:
Cardiovascular mortality
Ozone exposure
NAAQS (National Ambient Air Quality
Standards)
Environmental health policy
Air pollutionWhen identifying standards for air pollutants based on uncertain evidence, both science and policy judg-
ments play critical roles. Consequently, critical contextual factors are important for understanding the
strengths, limitations, and appropriate interpretation of available science, and potential beneﬁts of risk
mitigation alternatives. These factors include the relative magnitude and certainty of the risks posed
by various factors and the impacts of other risk factors on air pollutant epidemiology study ﬁndings.
This commentary explores ozone’s status as a risk factor for cardiovascular mortality in contrast with
decades of strong and consistent evidence for other established risk factors. By comparison, the ozone
evidence is less conclusive, more heterogeneous, and subject to substantial uncertainty; ozone’s potential
effects, if any, are small and challenging to discern. Moreover, the absence of a demonstrated causal
relationship calls into question efforts to quantify cardiovascular mortality risks attributed to ozone
exposures on a population level and highlights the need to explicitly acknowledge this uncertainty if such
calculations are performed. These concerns are relevant for other similar policy contexts – where multi-
ple established risk factors contribute to the health impact of interest; exposure-effect associations are
relatively small, weak, and uncertain; and a causal relationship has not been clearly established.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
When identifying health-protective standards for air pollutants
based on uncertain evidence, both science and policy judgments
play critical roles. For example, while the process of setting
National Ambient Air Quality Standards (NAAQS) for criteria air
pollutants includes developing ‘‘a concise review, synthesis, and
evaluation of the most policy-relevant science to serve as a scien-
tiﬁc foundation’’ for determining the NAAQS, the decision regard-
ing the level and form of the NAAQS ‘‘is a policy choice left
speciﬁcally to the Administrator’s judgment’’ (U.S. EPA, 2013). As
detailed in McClellan (2012), it is particularly important to distin-
guish among those aspects of the standard setting process that
reﬂect scientiﬁc determinations and those that are policy judg-
ments. Moreover, it is important to ensure that the standard set-
ting process compiles contextual information relevant for the
necessary policy choices (McClellan, 2012).Consequently, critical contextual factors can and should play an
important role in understanding both the strengths and limitations
of the available science and the implications of policy choices. For
example, to fully evaluate whether proposed changes to air quality
standards will improve health, it is useful to consider not only how
air pollutant exposures might contribute to speciﬁc health effects,
but also to compare these potential impacts with those of other
known risk factors. In making this comparison, policy decision
makers should consider both the relative magnitude of the risks
and the relative strength of the evidence supporting associations.
Placing potential health risk estimates from air pollution exposures
in a more complete context for policy decisions becomes increas-
ingly important as air quality standards are reduced to levels that
are near background levels and difﬁcult to meet, and are based on
scientiﬁc evidence reﬂecting greater degrees of uncertainty regard-
ing the nature and magnitude of potential health impacts.
Comparing the estimated magnitude and certainty of ozone health
impacts to that of other known risk factors provides a useful per-
spective on the potential beneﬁts of risk mitigation alternatives.
Similarly, insights regarding appropriate uses of available evidence
can result from reviewing the relative strength of the evidence for
a causal relationship between the health effect of interest and
ozone versus that for other risk factors. As a case study of these
1 Cardiovascular disease is typically deﬁned by ICD-9 codes 390-405, 410-449, 451-
459, and 745-747; and ICD-10 codes of I00-I99 and Q20-Q28 (NIH, 2012 being
catalogued).
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tor for cardiovascular mortality and reviews the information avail-
able for ozone in the context of that for other well-established risk
factors.
The US Environmental Protection Agency (US EPA) is mandated
by the Clean Air Act to develop NAAQS for six air pollutants
(including ozone), using a process that integrates numerous types
of scientiﬁc evidence. In a recent re-evaluation of the NAAQS for
ozone, US EPA reviewed studies addressing a broad range of poten-
tial health effects, reﬂecting a variety of study types and both
short- and long-term exposures (deﬁning short-term exposures
as those occurring over a period of hours, days, or weeks, and
long-term exposures as those occurring over periods of months
to years; US EPA, 2013). Of the six categories of health effects
explored, US EPA determined that the evidence for only one is
reﬂective of a ‘‘causal’’ relationship – i.e., respiratory morbidity fol-
lowing short-term ozone exposures – and focused primarily on
respiratory effects and overall mortality in its discussion of health
effects of concern for ozone. For all of the other health effects cate-
gories, US EPA assigned categories indicating greater uncertainty in
the underlying evidence. For example, based in part on data lim-
itations and the lack of coherence between results observed in epi-
demiology and animal toxicology studies (which US EPA identiﬁed
as ‘‘an important uncertainty’’ p.2–29), US EPA characterized the
evidence of cardiovascular or mortality effects following short-
term exposures as ‘‘likely’’ to reﬂect a causal relationship.
Indicating an even greater degree of uncertainty in the limited
available data, US EPA characterized the evidence of cardiovascular
or mortality effects following long-term exposures as only ‘‘sug-
gestive’’ of a causal relationship.
Cardiovascular disease is the leading cause of morbidity and
mortality in the US, and health organizations such as the
American Heart Association (AHA) have led large nationwide ini-
tiatives to reduce the overall burden of this disease in the US
population (Lloyd-Jones et al., 2010). Strong temporal and geo-
graphic variations in cardiovascular disease mortality have been
observed. For example, Fig. 1 illustrates how the US death rate
for cardiovascular disease has steadily declined since 1979, while
Fig. 2 shows how recent (2005–2007) US death rates for cardio-
vascular disease vary by geographic region (NIH, 2012).
Temporal and geographic differences in the death rates are
attributed to changes in population levels of various established
risk factors for cardiovascular disease and mortality (discussed
further below), as well as increasing use of more effective treat-
ments and changing population demographics (e.g., the growth
in the proportion of older individuals in the US population)
(Lloyd-Jones et al., 2010).
A number of factors have been identiﬁed as risk factors for mor-
tality related to cardiovascular health. These factors include mod-
iﬁable factors (i.e., factors that potentially can be changed by
individuals) such as body mass, and certain disease states, dietary
habits, activity patterns, and other behaviors (e.g., smoking). The
scientiﬁc support for the role of these recognized factors in cardio-
vascular disease mortality is considered sufﬁciently strong that
public health practitioners, policy makers, clinicians, and individu-
als routinely make or recommend making changes to these factors
to reduce risks of cardiovascular system-related disease and mor-
tality. Non-modiﬁable factors such as family history, age, race,
socioeconomic status, and exposures to extreme temperatures
are also well-recognized as playing an important role in cardio-
vascular mortality. Although these factors either cannot be chan-
ged or are less amenable to change, they also are considered
important in understanding cardiovascular mortality risks.
In contrast, a causal role for ozone in cardiovascular mortality
has not been established. As noted above, in its review of the scien-
tiﬁc literature for ozone health effects, US EPA recognized anumber of fundamental limitations and inconsistencies in the
available information regarding cardiovascular and mortality
effects. Moreover, two recent comprehensive weight-of-evidence
evaluations concluded that the strength of the evidence was not
sufﬁcient to conclude that short- or long-term ozone exposures
play a causal role in cardiovascular morbidity and mortality
(Goodman et al., 2014; Prueitt et al., 2014). Using an approach
based on one developed by the Institute of Medicine (IOM, 2008),
these evaluations instead categorized the evidence as ‘‘below equi-
poise,’’ indicating that ‘‘[t]he evidence is not sufﬁcient to conclude
that a causal relationship is at least as likely as not, or is not sufﬁ-
cient to make a scientiﬁcally formed judgment.’’ Other studies have
also called into question the causal role of ozone in mortality
(including cardiovascular mortality) and other cardiovascular
health impacts such as myocardial infarction (e.g., Smith et al.,
2009; Mustaﬁc et al., 2012).
Below, we review the strength of evidence and magnitude of
risk for factors traditionally recognized as contributors to cardio-
vascular mortality risk. This information is then compared to the
evidence available regarding the role of ozone in cardiovascular
mortality. We then discuss the role that established risk factors
may play in studies of ozone cardiovascular risks (e.g., as residual
confounders) and approaches for exploring the implications of
individual-level risk estimates for populations.2. Available evidence regarding cardiovascular mortality risk
factors
2.1. Established risk factors
Many decades of biomedical research have contributed to the
current state of knowledge regarding cardiovascular disease and
mortality. A number of established risk factors for cardiovascular
mortality have been well-described in the literature, including
modiﬁable risk factors (e.g., diet and smoking) as well as non-mod-
iﬁable personal characteristics (e.g., family history of cardio-
vascular disease) (Berry et al., 2012; Danaei et al., 2009;
Mittleman and Mostofsky, 2011). Fig. 3 displays relative risk (RR)
estimates for cardiovascular mortality associated with two broad
categories of risk factors: those analyzed as long-term/chronic risk
factors that occur over long periods of time, and short-term risk
factors (i.e., triggers), evaluated in epidemiology studies as events
that may precipitate an acute cardiovascular event immediately
following exposure. Additional information regarding the studies
in this ﬁgure is summarized in Table 1.
This case study focuses on mortality rather than morbidity
because cardiovascular disease often results in death, and mortal-
ity as a health endpoint can be measured in a relatively straightfor-
ward manner (van der Maas, 2003). Epidemiology studies of
cardiovascular disease mortality commonly use coding systems
such as the International Classiﬁcation of Diseases (ICD) to
characterize the causes of death reﬂected in their study datasets
(NIH, 2012).1 As a consequence, the various categories and subcate-
gories of mortality considered in such studies are well-deﬁned and
consistent across studies.
In selecting a RR estimate for each risk factor included in this
ﬁgure and table, we conducted a literature search to identify the
most recent and comprehensive perspectives on the evidence.
When available, we included results from recent pooled or meta-
analyses that present an integrated summary of results frommulti-
ple high-quality research investigations. Preference was given to
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Fig. 1. US age-adjusted death rates for cardiovascular diseases (1997–2008). Data source: NIH, 2012.
Fig. 2. US age-adjusted death rates for cardiovascular diseases by state.
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prospective cohort studies. When a recent pooled or meta- analysis
was not available, we extracted results from recent high-quality,
prospective cohort studies with a large number of participants.
Confounding was addressed in multivariate analysis in all individ-
ual and pooled analyses.
The literature review yielded a large number of meta-analyses
of cardiovascular disease and long-term/chronic risk factors, but
found fewer systematic reviews addressing acute triggers ofcardiovascular outcomes. For example, a recent review summar-
ized several dozen individual studies describing the risk of cardio-
vascular outcomes immediately following a wide variety of
physical, chemical, psychological, and environmental triggers, but
identiﬁed very few meta-analyses that have been conducted to
synthesize ﬁndings (Mittleman and Mostofsky, 2011). In addition,
although we identiﬁed studies addressing risks from episodic
exposures (e.g., the risk of myocardial infarction in the hour follow-
ing cocaine use is quite high: RR = 23.7, 95% conﬁdence interval
Fig. 3. Risk estimates for cardiovascular mortality risk factors.
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tively infrequent on a population-level basis and are not likely to
have a large impact on typical individual risk levels. As a result,
the acute risk factors included in our compilation focus on factors
that individuals most commonly encounter in day-to-day life.
We used a similar approach to identify estimates of the risks
associated with ozone exposures. For short-term exposures to
ozone, results were drawn from the largest, most recent meta-
analysis (Bell et al., 2005). Fewer epidemiology studies of long-
term ozone exposure and mortality have been conducted, and no
meta-analysis of this relationship was identiﬁed. Therefore, esti-
mates for the associations between long-term exposure and car-
diovascular mortality were drawn from the recent systematic
weight-of-evidence review of cardiovascular effects and long-term
ozone exposure (Prueitt et al., 2014). Other risk estimates identi-
ﬁed in this comprehensive review for speciﬁc cardiovascular-re-
lated causes of mortality (e.g., coronary heart disease and
myocardial infarction, two subgroups of cardiovascular disease)
were similar in magnitude and precision (Prueitt et al., 2014).
In general, the summary risk estimates reported for established
long-term/chronic risk factors are relatively large in magnitude,
have relatively tight 95% CIs, and have been replicated in many
studies conducted in a wide array of settings. Some uncertainties
arise when directly comparing the magnitude of risk estimates
associated with different risk factors measured using different
units. For example, the 39% increase in individual risk associated
with a 5-unit increase in body mass index (BMI) is not necessarily
directly comparable to the 28% increase in risk associated with an
increase in blood pressure (as reﬂected in a prehypertension
diagnosis) compared to normal blood pressure status. However,
in compiling the RR estimates included in Table 1 and Fig. 3, values
were selected to reﬂect comparison characteristics that would be
‘typical’ of the general population (e.g., interquartile comparisons)
rather than selecting values reﬂecting extreme population subsets.Moreover, the compiled risk estimates for established long- and
short-term risk factors demonstrate strong and relatively certain
relationships with cardiovascular mortality, with the estimates
for long-term/chronic risk factors ranging in magnitude from a
nearly threefold increase in individual risk associated with being
a current smoker down to a 4% increase in risk for consuming
one fewer serving of fruits and vegetables each day.
In fact, the observed associations with these risk factors are so
consistent that mathematical risk models have been derived to
predict an individual’s probability of developing cardiovascular
disease; these models have been used to advise individuals on
how to improve their cardiovascular health. The most well known
and widely used is the Framingham General Cardiovascular Risk
Score, used to estimate an individual’s 10-year risk of cardio-
vascular disease based on established risk factors such as sex,
age, blood pressure, smoking status and diabetes status
(D’Agostino et al., 2008). A simpliﬁed version of this approach –
the Healthy Heart Score Cardiovascular Health Calculator – has
recently been made available on-line to provide people with a
readily accessible way to assess their cardiovascular disease risk
based on information regarding their smoking habits, weight,
physical activity, alcohol use, and diet (Harvard School of Public
Health, 2014). An alternative prediction score is QRISK2, which
adds information on characteristics such as family history, BMI,
and income/deprivation, and demonstrates improved prediction
accuracy in some populations (Hippisley-Cox et al., 2008).
Similarly, the high conﬁdence in the strength of causal relation-
ships for established long-term/chronic cardiovascular risk factors
has led to substantial efforts to shape national healthcare policy
related to health promotion and disease reduction. Over the past
four decades, a substantial decrease in cardiovascular mortality
has been observed in the US, attributed not only to advances in
medical treatment in prolonging survival following cardiovascular
disease incidence, but also to the success of population-wide
Table 1
Summary of selected epidemiology research on cardiovascular mortality.
Risk factor Citation Study description Sample size Comparison for risk estimate Risk estimatea 95% CI
Long-term/chronic risk factors/exposures
Diabetes Barr et al., 2007 Cohort study 10,428
subjects
Known diabetes mellitus HR = 2.6 1.4–4.7
Smoking Thun et al. (2013) Pooled analysis of
5 studies
421,702
men
Current vs. never smokers RR = 2.50 (men)b
RR = 2.86 (women)b
2.34–2.66
2.65–3.08
535,054
women
Sedentary
behavior
Wilmot et al. (2012) Meta-analysis of
18 studies
421,921
subjects
More vs. less sedentary HR = 1.90 1.36–2.66
Family history of
CVD
Ranthe et al. (2012) Cohort study 3,985,301
subjects
History of 1st degree relative with CVD
vs. no family history
RR = 1.72c 1.68–1.77
Exercise Nocon et al. (2008) Meta-analysis of
33 studies
883,372
subjects
Less vs. more physically active RR = 1.54 1.42–1.66
Socioeconomic
status
Beebe-Dimmer et al.
(2004)
Cohort study 3,087
subjects
Lower vs. higher household income HR = 1.47 1.14–1.91
Obesity/BMI Prospective Studies
Collaboration (2009)
Pooled analysis of
57 studies
894,576
subjects
5 unit increase in BMI HR = 1.39b 1.34–1.44
Alcohol
consumption
Ronksley et al. (2011) Meta-analysis of
21 studies
1,184,956
subjects
No vs. some alcohol consumption RR = 1.33 1.25–1.43
Elevated blood
pressure
Huang et al. (2014) Meta-analysis of
20 studies
1,129,098
subjects
Prehypertension vs. normal blood
pressure
HR = 1.28 1.16–1.41
Coffee
consumption
Crippa et al. (2014) Meta-analysis of
13 studies
997,000
subjects
No vs. 3 cups of coffee/day RR = 1.27 1.19–1.35
Chronic stress Russ et al. (2012) Pooled analysis of
10 studies
68,222
subjects
One standard deviation increase in
psychological distress score
HR = 1.22 1.14–1.31
Sleep Gallicchio and Kalesan
(2009)
Meta-analysis of
17 studies
104,408
subjects
Long vs. medium sleep duration RR = 1.21 1.11–1.32
Diet Soﬁ et al. (2008) Meta-analysis of 4
studies
404,491
subjects
Lower vs. greater adherence to
Mediterranean diet
HR = 1.10 1.05–1.15
Diet Wang et al. (2014) Meta-analysis of
10 studies
833,234
subjects
One fewer daily serving of fruits/
vegetables
HR = 1.04 1.00–1.08
Ozone Lipsett et al. (2011) Cohort study 101,784
subjects
10 ppb increase in long term ozone HR(adj.) = 0.97d 0.90–1.05
Ozone Jerrett et al. (2009) Cohort study 448,850
subjects
10 ppb increase long-term ozone HR(adj.) = 0.983d 0.971–0.994
Short-term/acute risk factors/exposures
Stress Moller et al. (2005) Case-crossover
study
1381
subjects
High pressure deadline at work RR = 6.0e 1.8–20.4
Physical and
sexual activity
Dahabreh and Paulus
(2011)
Meta-analysis of
10 studies
9150
subjects
Episode of physical or sexual activity RR = 3.45e 2.33–5.13
Anger Edmondson et al. (2013) Meta-analysis of 5
studies
Not
reported
Episode of acute anger RR = 3.11e 1.80–5.39
Bereavement Wicks et al. (2012) Case-crossover
study
490
subjects
Death or separation of family member RR = 1.6 1.1–2.4
Ozone Bell et al. (2005) Meta-analysis of
18 studies
Not
reported
10 ppb increase in daily ozone RR = 1.0111 0.9932–
1.0153
BMI = body mass index; CVD = cardiovascular disease; HR = hazard ratio; PM2.5 = particulate matter with a diameter 62.5 lm; RR = relative risk.
a Except when noted, outcome assessed is CVD mortality.
b Outcome is ischemic heart disease mortality.
c Outcome is CVD incidence.
d Results are adjusted for PM2.5.
e Outcome is myocardial infarction.
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(Lloyd-Jones et al., 2010). For example, the movement to ban
smoking in public places has been credited for an up to 17% reduc-
tion in the incidence of acute myocardial infarction (Meyers et al.,
2009). Similarly, substantial population-average declines in serum
total cholesterol as well as systolic blood pressure are estimated to
be responsible for 44% of the reduction in coronary heart disease
rates between 1980 and 2000 (Berry et al., 2012).
2.2. Ozone
In contrast to the established risk factors discussed above, risk
estimates for cardiovascular mortality and ozone exposure are
small in magnitude and heterogeneous across studies, calling into
question whether ozone plays a causal role in cardiovascular mor-
tality and, if so, the magnitude of any such exposure–response
association. In particular, two recent weight-of-evidence evalua-
tions concluded that the available research does not conclusivelysupport a ﬁnding that a causal relationship exists between cardio-
vascular effects and either short-term or long-term exposures to
ozone (Goodman et al., 2014; Prueitt et al., 2014). In these compre-
hensive reviews, studies were selected for inclusion and assigned
quality ratings based on pre-deﬁned criteria. These evaluations
integrated ﬁndings from epidemiology, controlled human expo-
sure, and animal studies. When synthesizing the available evi-
dence, greater weight was accorded to ﬁndings from higher
quality studies.
In the weight-of-evidence evaluation for short-term ozone
exposures (i.e., less than 30 days, as deﬁned by US EPA in its
Integrated Science Assessment (US EPA, 2013)), Goodman et al.
(2014) evaluated 171 studies, including 33 epidemiology studies
that examined associations between short-term exposures and
cardiovascular mortality (5 case-crossover and 28 time-series
studies). Most of the identiﬁed studies addressing cardiovascular
mortality were categorized as Tier I studies (i.e., the higher quality
rank in this evaluation). The results observed in these studies were
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mortality being reported in both types of studies. As shown in
Table 1, the central tendency RR estimate from Bell et al. (2005;
the most recent meta-analysis of short-term ozone exposures
reﬂecting 39 studies conducted in the US and elsewhere) was
slightly greater than one (1.0111). However, this association was
not statistically signiﬁcant (95% CI: 0.9932–1.0153). The Bell
et al. (2005) analysis also indicated a high degree of heterogeneity
in the ﬁndings of the underlying studies, as well as evidence of
publication bias in the literature [i.e., the likelihood that studies
or analyses indicating an association (or larger association)
between ozone exposures and effects were more likely to be pub-
lished than those indicating null, negative, or smaller associations].
Goodman et al. (2014) identiﬁed heterogeneity (e.g., among study
areas), possible measurement error and confounding, and other
issues as key sources of uncertainty regarding the relationship
between short-term ozone exposures and cardiovascular mortal-
ity. Overall, the review concluded that ‘‘the totality of the evidence
from the large number of Tier I studies does not support a causal
relationship between [short-term] ozone exposure and CV
mortality.’’
In the weight-of-evidence evaluation for long-term ozone expo-
sures (i.e., greater than 30 days), Prueitt et al. (2014) evaluated 32
studies, including 12 epidemiology studies that examined associa-
tions between long-term exposures and cardiovascular mortality
(10 cohort and 2 ecological studies). All of the identiﬁed studies
addressing cardiovascular mortality were categorized as Tier I
studies. The results observed in these studies were variable, with
ﬁve of the cohort studies reporting a statistically signiﬁcant
increase in cardiovascular mortality in at least one analysis, and
the other ﬁve cohort studies (as well as the two ecological studies)
reporting null or negative results. Most of the reported associations
between long-term ozone exposures and cardiovascular mortality
were weak and close to unity (e.g., with central tendency RR esti-
mates generally ranging from approximately 0.97–1.03).
Moreover, many studies indicated potential confounding by other
pollutants. The results for the two large cohort studies that pro-
vided RR estimates for cardiovascular mortality listed in Table 1
illustrate these features of the ozone evidence. Speciﬁcally, for both
the Lipsett et al. (2011), Jerrett et al. (2009) studies, the estimated
hazard ratio was 1.00 or slightly greater (1.014) when the results
were not adjusted for exposures to PM2.5 (particulate matter with
a diameter62.5 lm), but were less than 1 (i.e., 0.97 or 0.983) when
the results were adjusted. (Both Lipsett et al. (2011), Jerrett et al.
(2009) considered multiple other risk factors in their analyses,
e.g., demographic characteristics, smoking history, alcohol use,
and diet.) In addition to confounding by other air pollutants,
Prueitt et al. (2014) identiﬁed possible exposure measurement
error and other key sources of uncertainty regarding the relation-
ship between long-term ozone exposures and cardiovascular mor-
tality that could also bias these risk estimates. Overall, the review
concluded that ‘‘the totality of the evidence does not support a cau-
sal relationship between long-term ozone exposure and CV
mortality.’’
Thus, in contrast with the available data for the established risk
factors for cardiovascular mortality, the risk estimates for ozone
are weaker, less consistent, subject to greater uncertainty, and
insufﬁcient to support the hypothesis that ozone is a causal factor
of cardiovascular mortality.3. Evidence interpretation and policy applications
The contrast between the available evidence regarding estab-
lished risk factors for cardiovascular mortality and that for ozone
highlights several observations relevant for evidenceinterpretation and application in policy settings. Clearly, even if
it were to be assumed that ozone plays a causal role in cardio-
vascular mortality, the difference in magnitude in the RR estimates
indicates the more limited impact that changes to ozone exposure
levels would have on an individual’s risk of cardiovascular mortal-
ity relative to the changes that would be expected to result from
modiﬁcations to the established risk factors. In addition, the
greater uncertainty inherent in the ozone risk estimates similarly
yields greater uncertainty regarding the beneﬁts that could be
derived from changes in ozone exposures. As discussed below,
the existence of numerous established risk factors for cardio-
vascular mortality affects the accuracy with which associations
between cardiovascular mortality and ozone exposure can be esti-
mated in epidemiology investigations. Moreover, the signiﬁcant
degree of uncertainty regarding the existence of a causal relation-
ship between ozone exposure and cardiovascular outcomes limits
the types of analyses that can be conducted using the available
evidence.
3.1. Role of established risk factors as confounders in ozone analyses
The strong and accepted causal relationships between numer-
ous established risk factors and cardiovascular disease and mortal-
ity have important implications for deriving accurate, unbiased
estimates of associations between cardiovascular mortality and
air pollutant exposures. As one example, in ecological studies of
long-term ozone exposure, mortality rates in different cities are
analyzed with respect to city-wide ozone concentrations averaged
over long periods of time (Janke et al., 2009; Wang et al., 2009).
However, the prevalence of important cardiovascular risk factors
such as smoking, obesity, dietary habits, and others likely vary
between cities and potentially confound the observed relation-
ships between cardiovascular mortality and ozone. For example,
it is possible that metropolitan areas in the US with the lowest con-
centrations of air pollutants have residents who are more afﬂuent
and generally healthy. This possible source of bias can be reduced
by adjusting for area-wide measures of demographics and other
census-based characteristics, such as percentage of households in
a census tract living below the poverty line, a factor often used
as a proxy measure for several cardiovascular risk factors.
However, residual confounding is likely to remain because aggre-
gate measures of population characteristics are poor representa-
tions of individual-level characteristics. A related but distinct
issue is that spatial autocorrelation in distributions of cardio-
vascular risk factors may lead to an underestimation of standard
errors and an increased occurrence of false positive results
(Jerrett et al., 2003), potentially resulting in incorrect assessments
of the magnitude or certainty of the association between an expo-
sure (e.g., to an air pollutant such as ozone) and the outcome of
interest.
As an alternative to an ecological study design, effects of long-
term air pollutant exposure can be estimated using a cohort design,
in which individual-level information on research subjects is col-
lected, typically by written questionnaire (Lipsett et al., 2011;
Jerrett et al., 2009). In theory, adjustment for all sources of these
individual-level confounders can produce unbiased estimates of
health effects. However, successful control for confounding is
dependent upon the accuracy of self-reported personal character-
istics such as body weight, dietary habits, and smoking history,
all of which are well-established risk factors for cardiovascular
mortality, as described above. Misclassiﬁcation of these covariates
can bias measured epidemiologic associations in ways that are dif-
ﬁcult to predict (Fewell et al., 2007; Rothman et al., 2008). In addi-
tion, some cohort studies of long-term ozone exposure rely upon
some ecological estimates of potential confounders when collect-
ing information on all individual-level risk factors is not possible
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in these cohort studies and can result in effect estimates that are
biased high or low.
In contrast to long-term studies, investigations of short-term
exposures are conducted using time-series or case-crossover
designs, in which the daily rates of adverse cardiovascular events
for a single study population are analyzed with respect to daily
ﬂuctuations in ozone concentration. For this reason, risk factors
that are relatively constant over short time frames, such as smok-
ing or socioeconomic status, cannot confound the measured
associations; only cardiovascular risk factors that vary in time on
a similar scale as the ﬂuctuations in exposure and outcome can
act as confounders. As a result, most of the established risk factors
discussed above have less of an impact on the results of short-term
exposure studies. Still, these studies have other methodological
limitations. The most important confounders of short-term studies
are temporal trends – both seasonal and long-term – as well as
time-varying meteorological conditions, such as temperature and
relative humidity. Generally, investigators control for these factors
by including smoothing functions of time, temperature, and rela-
tive humidity in statistical models. However, there exist a wide
variety of mathematical functions that can be used for these
adjustments, and there is no general consensus as to the best func-
tion to use (e.g., Lumley and Sheppard, 2003). In fact, it has been
demonstrated that results of air pollutant studies are sensitive to
the types and forms of smoothing function chosen to control for
temporal and meteorological trends (Sacks et al., 2012). Overall,
these methodological limitations and others contribute signiﬁcant
uncertainty to air pollution epidemiology results and have impor-
tant implications for estimating risks associated with ozone
exposure.
In addition, it has been hypothesized that other time-varying
risk factors may confound associations in air pollution time series
studies (Bukowski, 2008). For example, episodes of increased traf-
ﬁc exposure may induce acute stress (an established trigger of car-
diovascular mortality) and, consequently, lead to elevated risk of
cardiovascular outcomes. At the same time, increased trafﬁc den-
sity correlates with higher levels of air pollution. Bukowski
(2008) proposed that these correlations with stress could bias
the measured associations between air pollution and adverse
health, but others have argued that such bias is unlikely because
variations in both air pollution and stress are unlikely to occur con-
sistently in time and throughout a population in a manner that
would yield confounding (Goldberg et al., 2008).
These multiple sources of confounding and the likelihood of
residual confounding in spite of statistical adjustment call into
question the validity of the results of studies of ozone and cardio-
vascular mortality. In particular, this question arises because true
impacts, if any, are necessarily small in magnitude (i.e., if the
impacts were large in magnitude, they should have been more
readily detected in light of the prevalence of exposures). The mag-
nitude of bias that can result from residual confounding by tem-
poral trends or meteorology has been shown to be comparable in
size to the magnitude of measured associations between speciﬁc
air pollutant exposures and health impacts (Lumley and
Sheppard, 2000). In addition, a common practice is to conduct
thorough sensitivity analyses to assess the robustness of results
to variations in model speciﬁcation. Because air pollution epi-
demiology models incorporate numerous aspects that can be
explored, the number of alternative statistical analyses can be
extensive. As a result, air pollution epidemiology studies can be
particularly prone to model selection bias, when researchers
choose to report results of models that demonstrate positive, sta-
tistically-signiﬁcant associations (Dominici et al., 2008; Lumley
and Sheppard, 2003). This problem is further exacerbated by
publication bias, the tendency of researchers to submit – andjournals to publish – articles describing positive results. As noted
above, a meta-analysis of cardiovascular mortality and short-term
ozone exposures described signiﬁcant evidence for publication bias
in the collection of individual studies (Bell et al., 2005).
Given the methodological challenges inherent in estimating
small risk estimates and the potential inﬂuence of model selection
and publication biases, researchers have called for improved and
standardized methods for the ﬁeld of air pollutant epidemiology
(Lumley and Sheppard, 2003). Because the cardiovascular mortal-
ity risk estimates for established risk factors are larger in magni-
tude than those estimated for ozone exposures, they are less
susceptible to these sources of uncertainty and potential bias
inherent in the air pollutant research literature.
3.2. Application of epidemiology associations to policy decisions
The discussion above focuses on relative risks, which are
individual-level estimates of cardiovascular risk associated with a
speciﬁc risk factor or exposure. This approach can be helpful in
guiding individual-level decisions about whether to modify one’s
behavior to mitigate personal risks of cardiovascular impacts. For
example, an individual aiming to pursue a healthier lifestyle may
consider that reducing their BMI by 5 units could reduce their car-
diovascular mortality risk by approximately 40% (Prospective
Studies Collaboration, 2009). However, developing a perspective
on population-level health risks requires accounting for the pro-
portion of individuals who are exposed to a given risk factor.
Several epidemiology metrics have been developed to quantify
the burden of disease in a given population attributable to speciﬁc
risk factors. One example of such a metric is the population attri-
butable fraction (PAF), i.e., the proportion of disease in a population
attributable to a given exposure (Steenland and Armstrong, 2006).
The PAF can be calculated using only two quantities: the RR and
the percentage of the population exposed to the risk factor of inter-
est. Despite the simplicity of this calculation, inevitable uncertain-
ties in either of these parameters limit the precision of the
calculated PAF. Rigorous uncertainty analysis is recommended
when calculating and interpreting PAF estimates, including careful
consideration of how measurement errors in confounding factors
may impact RRs (Steenland and Armstrong, 2006).
Most importantly, the validity of PAF or other population-
focused calculations depends on the existence of a true causal
relationship between the risk factor or exposure and the outcome
of interest. As illustrated in Steenland and Armstrong (2006), this
assumption can strongly affect ﬁnal results. Speciﬁcally, they
describe the analyses of two research groups who independently
estimated the percentage of cancers attributable to occupational
exposures. These researchers reached different conclusions (i.e.,
5% vs. 14%) due to different assumptions regarding which occupa-
tional exposures were causally linked to cancer. In an ozone-re-
lated example, Mustaﬁc et al. (2012) conducted a meta-analysis
of studies describing short-term exposure to air pollutants and
incidence of myocardial infarction with the objective of calculating
PAFs attributable to various air pollutant exposures. However, in
conducting their meta-analysis, these researchers found that there
was no statistically signiﬁcant association between short-term
ozone exposures and myocardial infarction. These authors did
not calculate a PAF for ozone because they could not assume
causality.
This issue also arises in the August 2014 Health Risk and
Exposure Assessment (HREA) prepared by US EPA as one compo-
nent of its analyses supporting evaluation of the ozone NAAQS
(US EPA, 2014a). In this document, US EPA quantiﬁed potential
population-level ozone-related health effects, including ‘‘prema-
ture deaths’’ and ‘‘ozone-attributable mortality.’’ For example,
when estimating mortality impacts related to short-term ozone
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relationships presented in Smith et al. (2009), which analyzed
results from the National Morbidity Mortality Air Pollution Study
(NMMAPS), a study of mortality associated with short-term ozone
exposures in 95 urban US communities between 1987 and 2000.
US EPA used estimates of total mortality drawn from Smith et al.
(2009), stating that the total mortality estimates were ‘‘dominated
by’’ cardiovascular mortality. Notably, Smith et al. (2009)
expressed substantial reservations regarding the validity of the
ozone exposure-effect relationships presented in their study due
to the inconsistencies in observations in different cities and the
high degree of sensitivity of the study results to various modeling
and data choices. In particular, they were concerned that these
sources of uncertainty call into question whether a causal relation-
ship exists between ozone exposure and mortality. As discussed
above, with regard to cardiovascular mortality speciﬁcally, a com-
prehensive weight-of-evidence evaluation of the scientiﬁc litera-
ture also concluded that the available data did not conclusively
support the ﬁnding of a causal relationship between short-term
ozone exposures and cardiovascular effects (Goodman et al., 2014).
Although US EPA’s HREA evaluations addressed a number of
aspects of the epidemiology study results in sensitivity and uncer-
tainty analyses, the substantial uncertainties regarding whether
ozone actually plays a causal role in certain health endpoints were
not acknowledged when discussing the model results. US EPA
brieﬂy addressed the relative degree of information available for
different health effects when identifying effects included in the
analyses, e.g., discussing the conclusions presented in US EPA’s
Integrated Science Assessment for Ozone (US EPA, 2013) regarding
whether effects were categorized as reﬂecting a ‘‘causal relation-
ship,’’ ‘‘likely to be a causal relationship,’’ or ‘‘suggestive of a causal
relationship.’’ However, this important issue was not revisited later
in the document in the context of interpreting the modeling
results. For example, Table 7–4 of the HREA lists numerous sources
of uncertainties in US EPA’s risk modeling, focusing primarily on
various spatial and temporal features of the modeling assump-
tions. The fundamental uncertainty regarding whether ozone plays
a causal role in the modeled health effects is not included in this
table or associated discussion. Similarly, uncertainties concerning
causal determinations and potential implications for risk assess-
ment are not mentioned in the Proposed Rule for ozone, in which
the US EPA Administrator recommends lowering the ozone stan-
dard based in part on results of modeled health effects (US EPA,
2014b).
Similar concerns were raised regarding an earlier version of US
EPA’s analysis that was published in the peer-reviewed scientiﬁc
literature (Fann et al., 2012a,b; Cox, 2012). In the Fann analysis,
US EPA calculated ‘‘deaths’’ and ‘‘life years lost’’ in the US due to
exposures to several air pollutants, including ground-level ozone.
As noted by Cox (2012), the analyses as presented in Fann et al.
(2012a) treated observed statistical associations between pollutant
exposures and speciﬁc health effects as if they reﬂected proven
causal relationships. Moreover, Fann et al. (2012a) did not ade-
quately address differences in certainty that may exist for different
subsets of the analysis (e.g., for different pollutants or various cate-
gories of mortality or other health endpoints), how speciﬁc
quantitative concentration–response relationships were selected
for use in the population analyses, or the implications of alterna-
tive choices for the calculations. In particular, Cox (2012) noted
that presenting the health impact estimates without acknowledg-
ing that the true estimate of impacts could equal zero provides a
misleading perspective on the potential impacts of the pollutant
exposures and potential beneﬁts of reducing exposures.
As recognized in other analyses (e.g., Mustaﬁc et al., 2012 as dis-
cussed above), in some cases, conducting population-level calcula-
tions is not scientiﬁcally valid where a causal relationship has notbeen established. However, if such calculations are conducted
despite limitations in the available evidence, the high degree of
uncertainty surrounding the assumption of a causal relationship
should be recognized when discussing and interpreting the results.4. Conclusions
This review of the available evidence regarding the potential
role of ozone exposures in cardiovascular mortality relative to that
for established risk factors illustrates a number of fundamental
contextual issues in evaluating low-level environmental expo-
sures. These issues are relevant when evaluating any health end-
points for which there are numerous other causal risk factors
with more substantial and established effects, particularly in the
face of efforts to address smaller exposures that are accompanied
by greater uncertainty regarding the magnitude, nature, and exis-
tence of health effects at these low levels.
As illustrated in the evaluations presented in this paper, in con-
trast to the rich epidemiology database available for numerous
established risk factors for cardiovascular mortality, the evidence
of the potential role of ozone in cardiovascular mortality is less
conclusive, more heterogeneous, and subject to substantial uncer-
tainty. Moreover, the magnitude of potential effects, if any, is small
and challenging to discern (particularly in the presence of other
established factors). The uncertainties in the available evidence
limit the conclusions that can be conﬁdently drawn, as well as
the types of analyses that can be conducted (e.g., whether it is tech-
nically valid to calculate PAF values). The smaller magnitude and
greater uncertainty in the RR estimates for ozone relative to those
for the more established risk factors indicates the more limited, if
any, impact that changes to ozone exposure levels would have on
an individual’s risk of cardiovascular mortality. The existence of
established risk factors with more substantial effects also high-
lights the important contextual role that such information could
play in the policy judgments needed when deciding to reafﬁrm
or revise regulatory standards. Moreover, the absence of a demon-
strated causal relationship for ozone calls into question efforts to
quantify health impacts attributed to speciﬁc exposures on a pop-
ulation level, and highlights the need to explicitly acknowledge the
uncertainty in the causal relationships if such calculations are
performed.
Full consideration of the important contextual factors discussed
in this commentary is a necessary component of evaluating
whether policy decisions will effectively achieve public health pro-
tection goals. For example, as noted above, US EPA recently pro-
posed to lower the current NAAQS for ozone based on risk
models of population-level health effects attributable to ambient
ozone exposure, but did not fully acknowledge and account for
the substantial uncertainties in the causal relationship between
ozone and health effects, such as cardiovascular mortality, when
interpreting the results of its risk modeling (US EPA, 2014b). In
addition, although US EPA’s NAAQS documentation for ozone
(and other speciﬁc air pollutants) may address other established
risk factors for cardiovascular mortality (or other health effects of
interest) as potential inﬂuences on the ozone ﬁndings, the docu-
mentation does not typically discuss how the risks associated with
those factors compare with those attributed to air pollutant expo-
sures. That is, they are not discussed as risk factors in their own
right. As a result, although US EPA’s intent in its modeling process
was to generate conservative, protective estimates of potential
health impacts, the evaluations supporting the ozone Proposed
Rule do not adequately address the possibility that reducing the
air quality standards for ozone will not yield the estimated health
improvements, and do not provide the full suite of contextual
information that would help support the needed policy judgments.
C. Petito Boyce et al. / Regulatory Toxicology and Pharmacology 72 (2015) 107–116 115Although this commentary focuses on the potential effects of
ozone on cardiovascular mortality as a case study, the concerns
raised are relevant for other policy contexts with similar features
in the available evidence, including other health effects attributed
to ozone. Such features include instances where multiple estab-
lished risk factors contribute to the health impact of concern; the
effects associated with the exposure of interest are relatively small,
weak, and uncertain; and a causal relationship has not been clearly
established.
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